Deutsche starts MiniMed with Buy on attractive entry point

Deutsche Bank initiated coverage of MiniMed (MMED) with a Buy rating and $20 price target The stock’s current valuation provides an attractive entry point, the analyst tells investors in a research note. The firm believes the market has “reset expectations dramatically” for MiniMed, creating a favorable risk/reward looks attractive.